Press Release ImevaX welcomes KfW to investor syndicate in second closing of Series A financing Munich (Germany), March 02, 2015: ImevaX GmbH, a specialist in vaccines against pathogens of chronic infectious diseases, e

First Page		Document Content
Date: 2015-03-02 05:29:53 Clinical medicine Medicine Cancer RTT Infectious causes of cancer Helicobacter pylori Peptic ulcer Helicobacter Gastritis Stomach cancer KfW		Press Release ImevaX welcomes KfW to investor syndicate in second closing of Series A financing Munich (Germany), March 02, 2015: ImevaX GmbH, a specialist in vaccines against pathogens of chronic infectious diseases, e Add to Reading List Source URL: www.biomedvc.com Download Document from Source Website File Size: 222,30 KB Share Document on Facebook

	ORIGINAL ARTICLE doi:j00271.x NATURAL TRANSFORMATION INCREASES THE RATE OF ADAPTATION IN THE HUMAN PATHOGEN HELICOBACTER PYLORI DocID: 1sDtT - View Document
	Press Release ImevaX secures EUR 7.5 million in Series A Financing to develop highly specific vaccine against Helicobacter pylori infections Munich (Germany), October 28, 2014: ImevaX GmbH, a specialist in vaccines agai DocID: 1rRrC - View Document
	ImmunoCard STAT!® HpSA® HD NEXT GENERATION, HIGH DEFINITION RAPID TEST FROM THE LEADER IN STOOL ANTIGEN TESTING DEFINITIVE ANSWERS, CONFIDENT RESULTS® DocID: 1rtI8 - View Document
	Press Release ImevaX welcomes KfW to investor syndicate in second closing of Series A financing Munich (Germany), March 02, 2015: ImevaX GmbH, a specialist in vaccines against pathogens of chronic infectious diseases, e DocID: 1rjwj - View Document
	JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG, GERMANY Research Centre for Infectious Diseases (ZINF) PhD STUDENT Position “Virulence factors and regulators required during infections with the food-borne pathogen Campyloba DocID: 1r4bs - View Document